You are here

  • Home
  • Archive
  • Volume 4, Issue Suppl 3
  • OC 8721 WANECAM II – A CLINICAL TRIAL PROGRAMME TO ASSESS SAFETY, EFFICACY AND TRANSMISSION-BLOCKING PROPERTIES OF A NEW ANTIMALARIAL KAF156 (GANAPLACIDE) IN UNCOMPLICATED MALARIA IN WEST AND CENTRAL AFRICA

Article metrics

Article menu

Download PDFPDF

ABSTRACTS OF ORAL PRESENTATIONS
OC 8721 WANECAM II – A CLINICAL TRIAL PROGRAMME TO ASSESS SAFETY, EFFICACY AND TRANSMISSION-BLOCKING PROPERTIES OF A NEW ANTIMALARIAL KAF156 (GANAPLACIDE) IN UNCOMPLICATED MALARIA IN WEST AND CENTRAL AFRICA
Free

 

Online download statistics by month:

Online download statistics by month: April 2019 to March 2024

AbstractFullPdf
Apr 201936028
May 2019205013
Jun 2019632011
Jul 201927509
Aug 20197106
Sep 20192503
Oct 20194903
Nov 20194006
Dec 20194208
Jan 20203106
Feb 20203709
Mar 20202908
Apr 20201803
May 20202605
Jun 202014103
Jul 202057504
Aug 2020115304
Sep 202044304
Oct 20202607
Nov 20202404
Dec 20202304
Jan 20213206
Feb 20212907
Mar 20211804
Apr 20212504
May 2021502
Jun 2021004
Jul 20213012
Aug 2021004
Sep 2021103
Oct 202117020
Nov 202121015
Dec 20212803
Jan 20221603
Feb 20221102
Mar 20222206
Apr 20221202
May 202242010
Jun 20224403
Jul 20221906
Aug 20222905
Sep 20223905
Oct 20222706
Nov 20224504
Dec 20222401
Jan 202320015
Feb 20232000
Mar 20231300
Apr 20231905
May 20233405
Jun 20231905
Jul 20232003
Aug 20231901
Sep 20231202
Oct 20231001
Nov 20233106
Dec 20238403
Jan 2024600
Feb 20242404
Mar 202436052
Total47770387